Chinese Herbal Medicine-HK Sanlida Intl Healthcare Products

>>
Location: home > Products/FAQs > Holistic >

Old-Age Diabetes Treatment HK Sanlida

Google+

Holisticare (in capsules) can effectively prevent and treat diabetes mellitus and its complications.  A summing-up and analysis of relevant literature of late

Holisticare Capsule For Holistic Healing Remedies

 

years concerning clinical applications of Holisticare in China has been made, of which a part of the summaries of the therapeutic effects of that product is given hereunder for your reference.
(Note: All the patients mentioned below conform with the diagnostic criteria of diabetes mellitus of WHO 1999.)
Summary of clinical therapeutic effects (No.2)


Holisticare plus berberine for old-age diabetes mellitus Type II:


1. Method: 
A group of l53 elderly patients of diabetes mellitus Type II were distributed at random into a treatment group (102 people) and a contrast group (51 people), with each group going to take a course of treatment which was to last 2 months.  Both before and after the treatment an examination was to be made of each person to determine the levels of fasting blood sugar, postprandial 2h blood sugar and blood fat, accompanied with supplementary examinations to find out other variations.
Treatment group:  Each patient was to take orally Holisticare 2 pieces a time, 3 times a day, and to take jointly berberine at the dosage of 0.4g a time, 3 times a day qualified by the condition that the dosage might be varied a week later according to the requirement of the disease but the maximum dosage was to be 1.5g a day.
Contrast group:  Each patient was to take orally Diamicron 80mg. 2 times a day.
2. Criteria for judgement of effects:
 Outstandingly effective: Reduction of triglyceride>40%, reduction of cholesterol>20% and symptoms of diabetes mellitus have abated obviously.
 Effective: Reduction of triglyceride>20%, reduction of cholesterol>10% and symptoms of diabetes mellitus have somewhat lessened.
 Ineffective: The levels required by the criteria have not been reached, and there is no lessening of the symptoms.
3. Result:
The total rate of effectiveness for the treatment group and the contrast group respectively was 93.1%and 72.5%.  So far as the treatment group was concerned, data about the levels of fasting blood sugar, postprandial 2h blood sugar and blood fat were gathered before and after the treatment.  When the data gathered before the treatment was compared with those gathered after the treatment, they showed conspicuous differences.
Comparison of effects of blood-sugar reduction of the two groups:

 


 Groups  n  Notably Effective  Effective  Ineffective  Total rate(%)
Treatment   102  51  44  7  93.1
 Contrast  51  17  20  14  72.5


Comparison of blood-sugar levels before and after treatment of the two groups:


 Groups  n  Time  FPG  2hPG
 Treatment  102  before  [12.6-2.9] to [12.6+2.9]  [15.8-2.7] to [15.8+2.7]
     after  [6.9-1.1] to [6.9 +1.1]  [9.2-2.3] to [9.2 + 2.3]
 Contrast  51  before  [11.9-3.0] to [11.9+3.0]  [15.6-2.5] to [15.6+2.5]
     after  [9.1-2.2] to [9.1+2.2]  [11.8-2.8] to [11.8+2.8]

4. Other examinations of a supplementary nature:
The treatment group and the contrast group showed no apparent variation in hepatic and renal functions nor in blood routine examinations before and after the treatment.
Treatment group: There were 50 instances of myocardial ischemia on electrocardiograms before the treatment.  A reexamination on ECG after the treatment revealed improvement of various degrees.  The 8 instances of ventricular premature beat of frequent recurrences disappeared.
Contrast group: There were 25 instances of myocardial ischemia on electrocardiograms before the treatment.  The reexamination made after the treatment did not show any improvement.  The instances of ventricular premature beat did not disappear.
5. Unhealthy reactions: 
There were 2 instances of constipation in the treatment group, which did not interrupt the treatment.  There were no instances of hypoglycemic reaction or allergic reaction.  In the contrast group there was 1 instance of hypoglycemia.
6. Discussion:
Berberine was used clinically in the past as an antibacterial, anti-inflammatory medicine for treating intestinal infections.  With the deepening of research into the pharmacological effects of berberine, its clinical application is becoming more and more extensive.  In the last decade and a little earlier, reports have been coming successively from different quarters about the employment of berberine.
7. Conclusion:
Holisticare plus berberine can be used for treating elderly people’s diabetes mellitus Type II effectively.  They are highly valuable to those who have any cardio-cerebro-vascular disease.
Login And Download TCM Program
------分隔线----------------------------
Products/Columns Lists
Related content
You have read